Literature DB >> 11792718

Lipoprotein lipase is expressed in rat sciatic nerve and regulated in response to crush injury.

Patricia Uelmen Huey1, Kathleen C Waugh, Jacqueline Etienne, Robert H Eckel.   

Abstract

Male adult Sprague-Dawley rats were subjected to unilateral crush injury, and expression of LPL protein and mRNA were assessed as a function of time post-crush. LPL activity increased in the distal portion of the injured nerve by Day 4 post-crush, after which LPL activity gradually returned to normal levels. Conversely, quantification of LPL mRNA by reverse transcription-polymerase chain reaction demonstrated unchanged or decreased LPL mRNA in the distal nerve. Immunohistochemical analysis of LPL protein expression using an anti-rat LPL antibody revealed that LPL protein is present throughout the endoneurium of the sciatic nerve and increases in abundance following crush injury. The possibility that infiltrating macrophages are responsible for the increase in LPL protein levels in the crush injured nerve was addressed by immunohistochemical staining for ED-1, a differentiated macrophage marker protein. ED-1 was minimally present in the uninjured nerve and was detected at Day 4 post-crush, suggesting that the increase in LPL protein and activity that occurs following crush injury is at least partly derived from macrophages. These data suggest a role for LPL in the response of peripheral nerves to crush injury, possibly in order to facilitate reutilization of lipids from degenerating myelin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792718

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

Review 1.  Lipoprotein lipase in the brain and nervous system.

Authors:  Hong Wang; Robert H Eckel
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

Review 2.  A Role for Fatty Acids in Peripheral Neuropathy Associated with Type 2 Diabetes and Prediabetes.

Authors:  Amy E Rumora; Bhumsoo Kim; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2022-04-26       Impact factor: 7.468

3.  Abundance of triacylglycerols in ganglia and their depletion in diabetic mice: implications for the role of altered triacylglycerols in diabetic neuropathy.

Authors:  Hua Cheng; Shaoping Guan; Xianlin Han
Journal:  J Neurochem       Date:  2006-03-15       Impact factor: 5.372

4.  Lipoprotein lipase (LPL) is associated with neurite pathology and its levels are markedly reduced in the dentate gyrus of Alzheimer's disease brains.

Authors:  Huilin Gong; Weijiang Dong; Steven W Rostad; Santica M Marcovina; John J Albers; John D Brunzell; Simona Vuletic
Journal:  J Histochem Cytochem       Date:  2013-09-04       Impact factor: 2.479

5.  Gene expression pattern after insertion of dexamethasone-eluting electrode into the guinea pig cochlea.

Authors:  Yutaka Takumi; Shin-ya Nishio; Kenneth Mugridge; Tomohiro Oguchi; Shigenari Hashimoto; Nobuyoshi Suzuki; Satoshi Iwasaki; Claude Jolly; Shin-ichi Usami
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

6.  Lipoprotein Lipase Is a Feature of Alternatively-Activated Microglia and May Facilitate Lipid Uptake in the CNS During Demyelination.

Authors:  Kimberley D Bruce; Sachi Gorkhali; Katherine Given; Alison M Coates; Kristen E Boyle; Wendy B Macklin; Robert H Eckel
Journal:  Front Mol Neurosci       Date:  2018-03-15       Impact factor: 5.639

7.  Reduced Angiopoietin-Like 4 Expression in Multiple Sclerosis Lesions Facilitates Lipid Uptake by Phagocytes via Modulation of Lipoprotein-Lipase Activity.

Authors:  Alwin Kamermans; Merel Rijnsburger; Ananya Chakraborty; Susanne van der Pol; Helga E de Vries; Jack van Horssen
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

8.  Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain-Barré syndrome.

Authors:  Mária Péter; Wanda Török; Anna Petrovics-Balog; László Vígh; László Vécsei; Gábor Balogh
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.